These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32601324)

  • 1. Prevalence and incidence of visual impairment in patients with proliferative diabetic retinopathy in India.
    Khan R; Chandra S; Rajalakshmi R; Rani PK; Anantharaman G; Sen A; Desai A; Roy R; Natarajan S; Chen L; Chawla G; Behera UC; Gopal L; Gurudas S; Sivaprasad S; Raman R
    Sci Rep; 2020 Jun; 10(1):10513. PubMed ID: 32601324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Need for Vitreous Surgeries in Proliferative Diabetic Retinopathy in 10-Year Follow-Up: India Retinal Disease Study Group Report No. 2.
    Khan R; Surya J; Rajalakshmi R; Rani PK; Anantharaman G; Gopalakrishnan M; Sen A; Desai A; Roy R; Natarajan S; Chen L; Chawla G; Behera UC; Gopal L; Muralidharan V; Sivaprasad S; Raman R
    Ophthalmic Res; 2021; 64(3):432-439. PubMed ID: 33142294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in visual impairment prevalence by period of diagnosis of diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Klein R; Lee KE; Knudtson MD; Gangnon RE; Klein BE
    Ophthalmology; 2009 Oct; 116(10):1937-42. PubMed ID: 19616855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving visual prognosis of the diabetic patients during the past 30 years based on the data of the Finnish Register of Visual Impairment.
    Laatikainen L; Ojamo M; Rudanko SL; Summanen P; Keinänen-Kiukaanniemi S; Tuomilehto J; Herrala S; Uusitalo H
    Acta Ophthalmol; 2016 May; 94(3):226-31. PubMed ID: 26928978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
    Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual outcomes of pan-retinal photocoagulation in diabetic retinopathy at one-year follow-up and associated risk factors.
    Rema M; Sujatha P; Pradeepa R
    Indian J Ophthalmol; 2005 Jun; 53(2):93-9. PubMed ID: 15976463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study.
    Busch C; Fraser-Bell S; Zur D; Rodríguez-Valdés PJ; Cebeci Z; Lupidi M; Fung AT; Gabrielle PH; Giancipoli E; Chaikitmongkol V; Okada M; Laíns I; Santos AR; Kunavisarut P; Sala-Puigdollers A; Chhablani J; Ozimek M; Hilely A; Unterlauft JD; Loewenstein A; Iglicki M; Rehak M;
    Acta Diabetol; 2019 Jul; 56(7):777-784. PubMed ID: 30903434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions.
    Wubben TJ; Johnson MW;
    Am J Ophthalmol; 2019 Aug; 204():13-18. PubMed ID: 30878488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National prevalence of vision impairment and blindness and associated risk factors in adults aged 40 years and older with known or undiagnosed diabetes: results from the SMART-India cross-sectional study.
    Gurudas S; Vasconcelos JC; Prevost AT; Raman R; Rajalakshmi R; Ramasamy K; Mohan V; Rani PK; Das T; Conroy D; Tapp RJ; Sivaprasad S;
    Lancet Glob Health; 2024 May; 12(5):e838-e847. PubMed ID: 38430915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-year incidence and progression of visual impairment in a South Indian population with diabetes.
    Srinivasan S; Raman R; Ganesan S; Roy R; Natarajan V; Sharma T
    Indian J Ophthalmol; 2017 Jul; 65(7):589-595. PubMed ID: 28724816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of and risk factors for proliferative retinopathy and its association with blindness among diabetes clinic attenders.
    Janghorbani M; Jones RB; Allison SP
    Ophthalmic Epidemiol; 2000 Dec; 7(4):225-41. PubMed ID: 11262670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India.
    Rajalakshmi R; Behera UC; Bhattacharjee H; Das T; Gilbert C; Murthy GVS; Pant HB; Shukla R;
    Indian J Ophthalmol; 2020 Feb; 68(Suppl 1):S21-S26. PubMed ID: 31937724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    Gross JG; Glassman AR; Liu D; Sun JK; Antoszyk AN; Baker CW; Bressler NM; Elman MJ; Ferris FL; Gardner TW; Jampol LM; Martin DF; Melia M; Stockdale CR; Beck RW;
    JAMA Ophthalmol; 2018 Oct; 136(10):1138-1148. PubMed ID: 30043039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.
    Obeid A; Su D; Patel SN; Uhr JH; Borkar D; Gao X; Fineman MS; Regillo CD; Maguire JI; Garg SJ; Hsu J
    Ophthalmology; 2019 Mar; 126(3):407-413. PubMed ID: 30077614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States.
    Willis JR; Doan QV; Gleeson M; Haskova Z; Ramulu P; Morse L; Cantrell RA
    JAMA Ophthalmol; 2017 Sep; 135(9):926-932. PubMed ID: 28750122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
    Ip MS; Domalpally A; Sun JK; Ehrlich JS
    Ophthalmology; 2015 Feb; 122(2):367-74. PubMed ID: 25439595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathy.
    Klein R; Lee KE; Gangnon RE; Klein BE
    Ophthalmology; 2010 Jan; 117(1):63-70. PubMed ID: 19880184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25.
    Chew EY; Benson WE; Remaley NA; Lindley AA; Burton TC; Csaky K; Williams GA; Ferris FL
    Arch Ophthalmol; 1999 Dec; 117(12):1600-6. PubMed ID: 10604663
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.